Eloxx Pharmaceuticals entered into a debt facility of up to $30.0 million with Hercules Capital. Eloxx has drawn the initial tranche of $12.5 million and used the proceeds to repay in full amounts outstanding under the Company’s existing debt...
view press release
October 07, 2021, 08:00 AM
|
Antares Pharma, Inc. announced that it has entered into an amendment to its existing loan and security agreement with Hercules Capital, Inc. (HTGC), to increase the available debt capital by $25 million for a term loan of up to $50 million. The...
view press release
July 15, 2019, 09:00 AM
|
Hercules Capital, Inc., a specialty finance company, announced its many select investment and operating highlights for 2018.
“We completed a strong fourth quarter and culminated the year with total new investment commitments exceeding $1.21 billion...
view press release
January 08, 2019, 07:00 AM
|
Tricida, Inc., a South San Francisco, CA-based late-stage pharmaceutical company, entered into a $100 million venture debt facility with Hercules Capital, Inc.
Tricida drew down $25 million from the venture debt facility at closing. An additional...
view press release
March 06, 2018, 07:00 AM
|
Verastem, Inc., focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, announced its entry into an amendment to its Loan and Security Agreement with Hercules Capital, Inc., increasing its existing...
view press release
January 05, 2018, 07:15 AM
|
AVEO Oncology announced that it has completed the refinancing of its existing $20.0 million debt facility with Hercules Capital, Inc. and its affiliates, the terms of which enable approximately an additional $12.1 million in cash flow over 2018 and...
view press release
January 03, 2018, 08:00 AM
|
Hercules Capital, Inc., a specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, provided senior debt financing to support the merger of Solar Spectrum, a leader in the global solar market...
view press release
August 28, 2017, 08:00 AM
|
Hercules Capital, a specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, announced the addition of five seasoned professionals to its investment and credit teams. Joining the...
view press release
May 03, 2017, 08:00 AM
|
Hercules Capital, a specialty finance company, provided its interim portfolio update for the first quarter 2017. As of March 31, 2017, Hercules has originated $190.7 million of new debt and equity commitments to 12 new and existing portfolio...
view press release
April 17, 2017, 08:00 AM
|
Hercules Capital, Inc. provided its interim portfolio update for the fourth quarter 2016. “Our fourth quarter-to-date portfolio activity reflects another strong quarter of new origination and funding activities, closing over $200 million of new...
view press release
December 19, 2016, 07:40 AM
|
Rising short-term rates will likely provide an earnings boost to business development companies (BDCs) in the near term as LIBOR rates approach loan-specific floors, says Fitch Ratings. BDCs are generally interest rate sensitive asmost investment...
view press release
December 15, 2016, 07:46 AM
|
Edge Therapeutics, Inc., a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions, announced the closing of a $20 million dual-tranche term loan with Hercules Capital...
view press release
August 02, 2016, 08:02 AM
|
Hercules Capital, Inc. announced that effective March 8, 2016, it has expanded its credit facility with Wells Fargo Capital Finance, part of Wells Fargo & Company, under which AloStar Bank of Commerce has committed $20.0 million, for a total of $95.0...
view press release
March 08, 2016, 08:03 AM
|
Hercules Capital, Inc., a leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, announced the appointment of Jennifer McKay as Vice President of Human Resources.“We are excited to...
view press release
March 03, 2016, 08:06 AM
|
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, announced that it has entered into an amendment to its existing $15 million debt facility with Hercules Capital...
view press release
March 01, 2016, 07:41 AM
|
Hercules Capital announced that its Board of Directors has approved a $50 million open market share repurchase program. This program replaces a $50 million repurchase program which expired February 23, 2016.Under the program authorized by its Board...
view press release
February 25, 2016, 07:26 AM
|